Press-release for stocks related to alzheimer for LLY

Prices are updated after-hours

tags : Alzheimer symbols : LLY

save search

Quanterix Announces New Agreements with Lilly to Advance Alzheimer’s Disease Diagnosis and Treatment
Published: 2022-03-01 (Crawled : 13:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 196.93% | O: 1.26% H: 0.0% C: 0.0%
QTRX | $15.84 0.32% 0.32% 360K

Health Technology

| -51.34% | O: 3.95% H: 6.39% C: -6.56%
alzheimer treatment new agreements disease alzheimer’s alzheimer's disease alzheimer's diagnostic

Eli Lilly’s Two-Year Ambition Includes Alzheimer’s Approvals
Published: 2021-12-15 (Crawled : 19:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 191.25% | O: 4.7% H: 0.0% C: 0.0%
alzheimer als approval alzheimer’s alzheimer's

Marking One Year Milestone, ADDI Expands Access to Global Data for Alzheimer's Researchers
Published: 2021-11-17 (Crawled : 12:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 181.77% | O: -0.49% H: 0.0% C: 0.0%
alzheimer research alzheimer’s milestone alzheimer's

Quanterix’ Simoa® Technology Powers Advances in Alzheimer’s Disease Research Presented at 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Published: 2021-11-16 (Crawled : 15:30) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 181.05% | O: -0.26% H: 0.0% C: 0.0%
QTRX | $15.84 0.32% 0.32% 360K

Health Technology

| -71.24% | O: -0.84% H: 0.0% C: -1.52%
disease alzheimer clinical trials trials technology research trial conference alzheimer’s alzheimer's disease alzheimer's

AC Immune Announces First Positive Cognitive Results for a Tau-Targeting Monoclonal Antibody in Alzheimer’s Disease
Published: 2021-08-31 (Crawled : 12:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 176.89% | O: 0.2% H: 0.3% C: -1.73%
ACIU | $2.375 -0.21% -0.21% 320K

Health Technology

| -66.24% | O: 71.82% H: 5.0% C: -32.31%
disease alzheimer positive results antibody semorinemab alzheimer’s alzheimer's disease alzheimer's

Quanterix Simoa® Technology Powers Breakthrough Alzheimer’s Disease Research Presented by Eli Lilly and Company at Alzheimer’s Association International Conference (AAIC) 2021
Published: 2021-08-06 (Crawled : 13:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 174.92% | O: -0.18% H: 0.0% C: 0.0%
QTRX | $15.84 0.32% 0.32% 360K

Health Technology

| -72.21% | O: -2.26% H: 2.64% C: -5.91%
disease alzheimer technology research conference alzheimer’s alzheimer's disease alzheimer's

Lilly and Banner Alzheimer's Institute collaborate on planned Phase 3 prevention trial of donanemab
Published: 2021-07-15 (Crawled : 14:15) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 207.3% | O: -0.57% H: 0.42% C: -1.51%
alzheimer phase 3 trial collaboration alzheimer’s alzheimer's

Lilly's donanemab receives U.S. FDA's Breakthrough Therapy designation for treatment of Alzheimer's disease
Published: 2021-06-24 (Crawled : 11:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 234.55% | O: 8.21% H: 1.89% C: -0.83%
disease alzheimer treatment fda therapy breakthrough therapy alzheimer’s alzheimer's disease alzheimer's designation

Biogen’s Anuhelm Win Has Potential to Reinvigorate Alzheimer’s Investment
Published: 2021-06-08 (Crawled : 16:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -10.27% | O: 0.27% H: 0.23% C: -1.14%
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 226.4% | O: -0.36% H: 0.25% C: -0.46%
alzheimer potential alzheimer’s alzheimer's

AC Immune Provides Update on Alzheimer’s Disease Vaccine Candidates Targeting Pathological Amyloid-Beta
Published: 2021-06-02 (Crawled : 12:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 266.05% | O: 0.3% H: 0.96% C: 0.06%
ACIU | $2.375 -0.21% -0.21% 320K

Health Technology

| -62.95% | O: 9.89% H: 2.4% C: -9.71%
disease alzheimer vaccine aci-24 alzheimer’s alzheimer's disease alzheimer's

Data from Lilly at International Conference on Alzheimer's & Parkinson Diseases 2021™ (AD/PD™ 2021) to Showcase Clinical Advances in Alzheimer's Disease Research
Published: 2021-03-09 (Crawled : 16:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 250.82% | O: 0.63% H: 1.83% C: -1.07%
disease alzheimer parkinson research alzheimer’s alzheimer's disease alzheimer's

Lilly Announces Webcast to Provide Alzheimer's Disease Update at AD/PD Conference
Published: 2021-02-04 (Crawled : 22:08) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology